CN Patent

CN101347438A — 一种减缓眼部新生血管生成的药物

Assigned to TIANJIN PHARMACEUTICALS GROUP CORP · Expires 2009-01-21 · 17y expired

What this patent protects

本发明涉及一种甾体化合物(I)用于抑制眼部新生血管生成的药物中的应用。本发明涉及该种药物相关制剂的制备。

USPTO Abstract

本发明涉及一种甾体化合物(I)用于抑制眼部新生血管生成的药物中的应用。本发明涉及该种药物相关制剂的制备。

Drugs covered by this patent

Patent Metadata

Patent number
CN101347438A
Jurisdiction
CN
Classification
—
Expires
2009-01-21
Drug substance claim
No
Drug product claim
No
Assignee
TIANJIN PHARMACEUTICALS GROUP CORP
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.